FDA Drug information
Neurontin
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Neurontin GABAPENTIN 100 mg/1 Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 100 mg/1 Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 250 mg/5mL Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 250 mg/5mL Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 300 mg/1 Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 300 mg/1 Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 400 mg/1 Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 400 mg/1 Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 600 mg/1 Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 600 mg/1 Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 800 mg/1 Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 800 mg/1 Parke-Davis Div of Pfizer Inc
- Neurontin GABAPENTIN 800 mg/1 Parke-Davis Div of Pfizer Inc
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.